

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.91870135 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.44580141 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.44580141 |
| 4 | positive regulation of B cell differentiation (GO:0045579) | 5.07899988 |
| 5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.04368063 |
| 6 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.91095788 |
| 7 | detection of other organism (GO:0098543) | 4.88491754 |
| 8 | detection of bacterium (GO:0016045) | 4.73297035 |
| 9 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.45277817 |
| 10 | regulation of B cell differentiation (GO:0045577) | 4.28633977 |
| 11 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.23448909 |
| 12 | definitive hemopoiesis (GO:0060216) | 4.21862676 |
| 13 | regulation of gamma-delta T cell activation (GO:0046643) | 4.20586905 |
| 14 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.14977024 |
| 15 | detection of external biotic stimulus (GO:0098581) | 4.06404572 |
| 16 | ribosomal small subunit assembly (GO:0000028) | 4.02880762 |
| 17 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.01481709 |
| 18 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.00411053 |
| 19 | negative regulation of cell killing (GO:0031342) | 4.00411053 |
| 20 | leukocyte aggregation (GO:0070486) | 3.96797339 |
| 21 | megakaryocyte development (GO:0035855) | 3.96091717 |
| 22 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.92965515 |
| 23 | B cell receptor signaling pathway (GO:0050853) | 3.88661495 |
| 24 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.86391328 |
| 25 | microglial cell activation (GO:0001774) | 3.80088280 |
| 26 | negative regulation of phagocytosis (GO:0050765) | 3.79412178 |
| 27 | negative regulation of T cell mediated immunity (GO:0002710) | 3.76440048 |
| 28 | detection of molecule of bacterial origin (GO:0032490) | 3.74930855 |
| 29 | positive regulation of mast cell activation (GO:0033005) | 3.74681929 |
| 30 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.72166084 |
| 31 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.70786166 |
| 32 | response to host immune response (GO:0052572) | 3.70786166 |
| 33 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.67060133 |
| 34 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.66240868 |
| 35 | regulation of leukocyte degranulation (GO:0043300) | 3.64821493 |
| 36 | detection of biotic stimulus (GO:0009595) | 3.62510782 |
| 37 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.62007105 |
| 38 | positive thymic T cell selection (GO:0045059) | 3.54954577 |
| 39 | macrophage activation (GO:0042116) | 3.52420680 |
| 40 | mast cell activation (GO:0045576) | 3.49806572 |
| 41 | T cell homeostasis (GO:0043029) | 3.44141544 |
| 42 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.42797969 |
| 43 | response to host (GO:0075136) | 3.42797969 |
| 44 | response to host defenses (GO:0052200) | 3.42797969 |
| 45 | immunoglobulin mediated immune response (GO:0016064) | 3.42426281 |
| 46 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.41488106 |
| 47 | activated T cell proliferation (GO:0050798) | 3.40559635 |
| 48 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.35091623 |
| 49 | positive regulation of mast cell degranulation (GO:0043306) | 3.35091623 |
| 50 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.34507359 |
| 51 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.34458575 |
| 52 | respiratory burst (GO:0045730) | 3.32571545 |
| 53 | mature B cell differentiation (GO:0002335) | 3.31372877 |
| 54 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.31193375 |
| 55 | regulation of T cell tolerance induction (GO:0002664) | 3.30609049 |
| 56 | regulation of tolerance induction (GO:0002643) | 3.30533215 |
| 57 | neutrophil activation involved in immune response (GO:0002283) | 3.29203994 |
| 58 | myeloid dendritic cell activation (GO:0001773) | 3.28065474 |
| 59 | cellular extravasation (GO:0045123) | 3.27948559 |
| 60 | response to peptidoglycan (GO:0032494) | 3.26141608 |
| 61 | germinal center formation (GO:0002467) | 3.26134163 |
| 62 | modulation by symbiont of host immune response (GO:0052553) | 3.26067586 |
| 63 | positive regulation by symbiont of host defense response (GO:0052509) | 3.26067586 |
| 64 | modulation by symbiont of host defense response (GO:0052031) | 3.26067586 |
| 65 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.26067586 |
| 66 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.26067586 |
| 67 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.26067586 |
| 68 | neutrophil mediated immunity (GO:0002446) | 3.24524172 |
| 69 | pinocytosis (GO:0006907) | 3.23358850 |
| 70 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.22354440 |
| 71 | mature B cell differentiation involved in immune response (GO:0002313) | 3.15674859 |
| 72 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.14592227 |
| 73 | response to protozoan (GO:0001562) | 3.12493075 |
| 74 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.12074818 |
| 75 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.11629034 |
| 76 | response to muramyl dipeptide (GO:0032495) | 3.09458717 |
| 77 | regulation of regulated secretory pathway (GO:1903305) | 3.08302640 |
| 78 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.07932911 |
| 79 | defense response to protozoan (GO:0042832) | 3.06981535 |
| 80 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.05836599 |
| 81 | lymphocyte homeostasis (GO:0002260) | 3.05154535 |
| 82 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.04907129 |
| 83 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.03368008 |
| 84 | myeloid cell activation involved in immune response (GO:0002275) | 3.02099800 |
| 85 | mast cell degranulation (GO:0043303) | 3.01954296 |
| 86 | mast cell activation involved in immune response (GO:0002279) | 3.01954296 |
| 87 | negative thymic T cell selection (GO:0045060) | 2.99660504 |
| 88 | regulation of antigen processing and presentation (GO:0002577) | 2.99097616 |
| 89 | B cell homeostasis (GO:0001782) | 2.97976270 |
| 90 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.97870186 |
| 91 | regulation of erythrocyte differentiation (GO:0045646) | 2.97416489 |
| 92 | positive regulation of granulocyte differentiation (GO:0030854) | 2.97211131 |
| 93 | neutrophil activation (GO:0042119) | 2.95398850 |
| 94 | negative regulation of granulocyte differentiation (GO:0030853) | 2.95346916 |
| 95 | negative regulation of interleukin-6 production (GO:0032715) | 2.95224454 |
| 96 | negative T cell selection (GO:0043383) | 2.95219444 |
| 97 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.94167715 |
| 98 | negative regulation of innate immune response (GO:0045824) | 2.92679319 |
| 99 | cellular response to interleukin-15 (GO:0071350) | 2.92672422 |
| 100 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.92526284 |
| 101 | leukocyte homeostasis (GO:0001776) | 2.90417200 |
| 102 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.88613988 |
| 103 | cellular response to zinc ion (GO:0071294) | 2.87211175 |
| 104 | lymph node development (GO:0048535) | 2.86872550 |
| 105 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.86574642 |
| 106 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.86317795 |
| 107 | NIK/NF-kappaB signaling (GO:0038061) | 2.85086272 |
| 108 | negative regulation of interleukin-12 production (GO:0032695) | 2.84915655 |
| 109 | response to fungus (GO:0009620) | 2.83938070 |
| 110 | B cell mediated immunity (GO:0019724) | 2.79989680 |
| 111 | response to interferon-beta (GO:0035456) | 2.79365712 |
| 112 | myeloid dendritic cell differentiation (GO:0043011) | 2.77808644 |
| 113 | response to interleukin-15 (GO:0070672) | 2.77185600 |
| 114 | embryonic hemopoiesis (GO:0035162) | 2.77013489 |
| 115 | T cell migration (GO:0072678) | 2.76812661 |
| 116 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.76792035 |
| 117 | macrophage activation involved in immune response (GO:0002281) | 2.75160500 |
| 118 | regulation of necroptotic process (GO:0060544) | 2.74584946 |
| 119 | positive regulation of antigen processing and presentation (GO:0002579) | 2.72333235 |
| 120 | interferon-gamma production (GO:0032609) | 2.71639644 |
| 121 | natural killer cell differentiation (GO:0001779) | 2.71493943 |
| 122 | response to type I interferon (GO:0034340) | 2.70962502 |
| 123 | viral transcription (GO:0019083) | 2.70560488 |
| 124 | positive T cell selection (GO:0043368) | 2.69409149 |
| 125 | granulocyte activation (GO:0036230) | 2.68460696 |
| 126 | thymic T cell selection (GO:0045061) | 2.68058729 |
| 127 | leukocyte degranulation (GO:0043299) | 2.66907574 |
| 128 | type I interferon signaling pathway (GO:0060337) | 2.66003684 |
| 129 | cellular response to type I interferon (GO:0071357) | 2.66003684 |
| 130 | regulation of granulocyte differentiation (GO:0030852) | 2.65313582 |
| 131 | leukocyte cell-cell adhesion (GO:0007159) | 2.63990838 |
| 132 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.62244455 |
| 133 | cellular response to interferon-beta (GO:0035458) | 2.61536718 |
| 134 | tolerance induction (GO:0002507) | 2.59096996 |
| 135 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.57585537 |
| 136 | T cell selection (GO:0045058) | 2.55807313 |
| 137 | regulation of mast cell degranulation (GO:0043304) | 2.55438017 |
| 138 | defense response to fungus (GO:0050832) | 2.55055466 |
| 139 | positive regulation of interferon-alpha production (GO:0032727) | 2.55032977 |
| 140 | actin nucleation (GO:0045010) | 2.54493204 |
| 141 | angiogenesis involved in wound healing (GO:0060055) | 2.54300105 |
| 142 | hepatocyte apoptotic process (GO:0097284) | 2.53542795 |
| 143 | translational termination (GO:0006415) | 2.53414925 |
| 144 | regulation of mast cell activation (GO:0033003) | 2.52841267 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.20664326 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.18694685 |
| 3 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.94451514 |
| 4 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.87138130 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.57207224 |
| 6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.33570772 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.30712956 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.15702939 |
| 9 | MYC_22102868_ChIP-Seq_BL_Human | 3.06530576 |
| 10 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.04151309 |
| 11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.00463346 |
| 12 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.99817782 |
| 13 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.97058160 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.92295503 |
| 15 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.81943657 |
| 16 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.76639075 |
| 17 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.73922925 |
| 18 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.67559275 |
| 19 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.56165938 |
| 20 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.54281437 |
| 21 | MYB_26560356_Chip-Seq_TH2_Human | 2.29905282 |
| 22 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.27905606 |
| 23 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.24076311 |
| 24 | MAF_26560356_Chip-Seq_TH1_Human | 2.22209454 |
| 25 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.21596140 |
| 26 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.19582147 |
| 27 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.18454581 |
| 28 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.18088347 |
| 29 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.17365429 |
| 30 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.15943326 |
| 31 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.15335697 |
| 32 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.13049254 |
| 33 | * MYB_26560356_Chip-Seq_TH1_Human | 2.11918640 |
| 34 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.10381213 |
| 35 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.09506494 |
| 36 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.99872536 |
| 37 | UTX_26944678_Chip-Seq_JUKART_Human | 1.99639331 |
| 38 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.91932296 |
| 39 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.90622646 |
| 40 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89257494 |
| 41 | SPI1_23127762_ChIP-Seq_K562_Human | 1.88611193 |
| 42 | GATA1_22025678_ChIP-Seq_K562_Human | 1.86231296 |
| 43 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.78833690 |
| 44 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.77117057 |
| 45 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.76571423 |
| 46 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.75393004 |
| 47 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.74979830 |
| 48 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.68184075 |
| 49 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.64810140 |
| 50 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.63627722 |
| 51 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63235395 |
| 52 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.61928732 |
| 53 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.60802483 |
| 54 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.60788745 |
| 55 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.60170048 |
| 56 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.58705768 |
| 57 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.56178436 |
| 58 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.53780708 |
| 59 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.53546192 |
| 60 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.51953687 |
| 61 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.49693542 |
| 62 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.45419524 |
| 63 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.43754090 |
| 64 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.43501612 |
| 65 | MAF_26560356_Chip-Seq_TH2_Human | 1.38971650 |
| 66 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.37550598 |
| 67 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.37255464 |
| 68 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.36609228 |
| 69 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.35408898 |
| 70 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.32605994 |
| 71 | GATA1_19941826_ChIP-Seq_K562_Human | 1.31436720 |
| 72 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.30501540 |
| 73 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.30260607 |
| 74 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.28398200 |
| 75 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.27175161 |
| 76 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.27082767 |
| 77 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23022248 |
| 78 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20610348 |
| 79 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.16617566 |
| 80 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.16443494 |
| 81 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.13761650 |
| 82 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.13089600 |
| 83 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.12266425 |
| 84 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.09193830 |
| 85 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08469771 |
| 86 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.06501995 |
| 87 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.06334393 |
| 88 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.04273437 |
| 89 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.04040776 |
| 90 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02969927 |
| 91 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.02444478 |
| 92 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00805074 |
| 93 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.00243227 |
| 94 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.99325077 |
| 95 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.98919800 |
| 96 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.98580354 |
| 97 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97854282 |
| 98 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.97585277 |
| 99 | GATA2_19941826_ChIP-Seq_K562_Human | 0.97335457 |
| 100 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.95827520 |
| 101 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.94688344 |
| 102 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.94670171 |
| 103 | * GATA3_26560356_Chip-Seq_TH2_Human | 0.94578493 |
| 104 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.91893584 |
| 105 | * ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.91858520 |
| 106 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.87536533 |
| 107 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.87464831 |
| 108 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86313250 |
| 109 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.86070621 |
| 110 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.85526092 |
| 111 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.84820523 |
| 112 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84553842 |
| 113 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.84115800 |
| 114 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82652388 |
| 115 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81038093 |
| 116 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80913877 |
| 117 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.80617737 |
| 118 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.76696834 |
| 119 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.74680468 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.93142511 |
| 2 | MP0002396_abnormal_hematopoietic_system | 3.59395218 |
| 3 | MP0000685_abnormal_immune_system | 3.01517303 |
| 4 | MP0005671_abnormal_response_to | 2.87431470 |
| 5 | MP0004808_abnormal_hematopoietic_stem | 2.85882465 |
| 6 | * MP0001800_abnormal_humoral_immune | 2.84545476 |
| 7 | MP0003303_peritoneal_inflammation | 2.84335984 |
| 8 | MP0005174_abnormal_tail_pigmentation | 2.72466865 |
| 9 | MP0003436_decreased_susceptibility_to | 2.69247246 |
| 10 | * MP0002452_abnormal_antigen_presenting | 2.61592896 |
| 11 | * MP0005464_abnormal_platelet_physiology | 2.59919475 |
| 12 | MP0009785_altered_susceptibility_to | 2.59562523 |
| 13 | MP0005387_immune_system_phenotype | 2.55810116 |
| 14 | MP0001790_abnormal_immune_system | 2.55810116 |
| 15 | * MP0005025_abnormal_response_to | 2.54089025 |
| 16 | * MP0002419_abnormal_innate_immunity | 2.54020061 |
| 17 | MP0005000_abnormal_immune_tolerance | 2.52233173 |
| 18 | * MP0002420_abnormal_adaptive_immunity | 2.50646917 |
| 19 | * MP0002723_abnormal_immune_serum | 2.49892115 |
| 20 | MP0009278_abnormal_bone_marrow | 2.48963275 |
| 21 | MP0002398_abnormal_bone_marrow | 2.48532837 |
| 22 | * MP0001819_abnormal_immune_cell | 2.48475722 |
| 23 | MP0003763_abnormal_thymus_physiology | 2.45385858 |
| 24 | MP0005397_hematopoietic_system_phenotyp | 2.40257675 |
| 25 | MP0001545_abnormal_hematopoietic_system | 2.40257675 |
| 26 | MP0002148_abnormal_hypersensitivity_rea | 2.21290383 |
| 27 | MP0000716_abnormal_immune_system | 2.20275509 |
| 28 | MP0000465_gastrointestinal_hemorrhage | 2.17161304 |
| 29 | MP0000689_abnormal_spleen_morphology | 2.13786986 |
| 30 | MP0001873_stomach_inflammation | 2.13212094 |
| 31 | MP0002722_abnormal_immune_system | 2.05366915 |
| 32 | MP0002405_respiratory_system_inflammati | 2.05193189 |
| 33 | MP0002166_altered_tumor_susceptibility | 2.00737393 |
| 34 | MP0002429_abnormal_blood_cell | 1.92192465 |
| 35 | MP0003300_gastrointestinal_ulcer | 1.90645017 |
| 36 | MP0008260_abnormal_autophagy | 1.90290858 |
| 37 | MP0010155_abnormal_intestine_physiology | 1.86706307 |
| 38 | MP0000569_abnormal_digit_pigmentation | 1.85977465 |
| 39 | MP0003172_abnormal_lysosome_physiology | 1.76762073 |
| 40 | MP0000703_abnormal_thymus_morphology | 1.76338229 |
| 41 | MP0001853_heart_inflammation | 1.75249555 |
| 42 | MP0003724_increased_susceptibility_to | 1.72940623 |
| 43 | MP0006082_CNS_inflammation | 1.72799125 |
| 44 | MP0005058_abnormal_lysosome_morphology | 1.71370338 |
| 45 | MP0005075_abnormal_melanosome_morpholog | 1.71035818 |
| 46 | MP0001845_abnormal_inflammatory_respons | 1.67778406 |
| 47 | MP0003183_abnormal_peptide_metabolism | 1.67205245 |
| 48 | MP0009333_abnormal_splenocyte_physiolog | 1.65891465 |
| 49 | MP0000490_abnormal_crypts_of | 1.61085698 |
| 50 | MP0004947_skin_inflammation | 1.57006478 |
| 51 | MP0002006_tumorigenesis | 1.54785812 |
| 52 | MP0003866_abnormal_defecation | 1.49428788 |
| 53 | MP0005451_abnormal_body_composition | 1.45227084 |
| 54 | MP0000015_abnormal_ear_pigmentation | 1.36741305 |
| 55 | MP0002095_abnormal_skin_pigmentation | 1.34896245 |
| 56 | MP0004883_abnormal_blood_vessel | 1.30746409 |
| 57 | MP0003693_abnormal_embryo_hatching | 1.28372259 |
| 58 | MP0001533_abnormal_skeleton_physiology | 1.26924767 |
| 59 | MP0008469_abnormal_protein_level | 1.26273887 |
| 60 | MP0003690_abnormal_glial_cell | 1.25997753 |
| 61 | MP0004510_myositis | 1.24319578 |
| 62 | MP0010094_abnormal_chromosome_stability | 1.20919124 |
| 63 | MP0004381_abnormal_hair_follicle | 1.19602290 |
| 64 | MP0003191_abnormal_cellular_cholesterol | 1.18717854 |
| 65 | MP0001851_eye_inflammation | 1.18368766 |
| 66 | MP0008057_abnormal_DNA_replication | 1.15868714 |
| 67 | MP0000858_altered_metastatic_potential | 1.09853095 |
| 68 | MP0005310_abnormal_salivary_gland | 1.09564393 |
| 69 | MP0008004_abnormal_stomach_pH | 1.07206084 |
| 70 | MP0003077_abnormal_cell_cycle | 1.07178521 |
| 71 | MP0010307_abnormal_tumor_latency | 1.06752385 |
| 72 | MP0002019_abnormal_tumor_incidence | 1.06267608 |
| 73 | MP0000604_amyloidosis | 1.04991132 |
| 74 | MP0005166_decreased_susceptibility_to | 1.04731734 |
| 75 | MP0002933_joint_inflammation | 0.99201401 |
| 76 | MP0002009_preneoplasia | 0.95293138 |
| 77 | MP0005164_abnormal_response_to | 0.95122424 |
| 78 | MP0000343_altered_response_to | 0.90328369 |
| 79 | MP0002277_abnormal_respiratory_mucosa | 0.88897444 |
| 80 | MP0003111_abnormal_nucleus_morphology | 0.87841530 |
| 81 | MP0003943_abnormal_hepatobiliary_system | 0.86485528 |
| 82 | MP0005390_skeleton_phenotype | 0.84813225 |
| 83 | MP0008007_abnormal_cellular_replicative | 0.84810408 |
| 84 | MP0003566_abnormal_cell_adhesion | 0.84602118 |
| 85 | MP0010352_gastrointestinal_tract_polyps | 0.84329763 |
| 86 | MP0000371_diluted_coat_color | 0.83514902 |
| 87 | MP0003448_altered_tumor_morphology | 0.82781265 |
| 88 | MP0001663_abnormal_digestive_system | 0.82241895 |
| 89 | MP0000313_abnormal_cell_death | 0.82021653 |
| 90 | MP0008058_abnormal_DNA_repair | 0.81048704 |
| 91 | MP0009764_decreased_sensitivity_to | 0.79436908 |
| 92 | MP0003828_pulmonary_edema | 0.77865311 |
| 93 | MP0003656_abnormal_erythrocyte_physiolo | 0.75017448 |
| 94 | MP0002998_abnormal_bone_remodeling | 0.74463511 |
| 95 | MP0009763_increased_sensitivity_to | 0.71442942 |
| 96 | MP0009840_abnormal_foam_cell | 0.68574278 |
| 97 | MP0006054_spinal_hemorrhage | 0.67016336 |
| 98 | MP0002132_abnormal_respiratory_system | 0.66702736 |
| 99 | MP0002928_abnormal_bile_duct | 0.66213932 |
| 100 | MP0003806_abnormal_nucleotide_metabolis | 0.65989470 |
| 101 | MP0002138_abnormal_hepatobiliary_system | 0.65548320 |
| 102 | MP0003091_abnormal_cell_migration | 0.64677063 |
| 103 | MP0005076_abnormal_cell_differentiation | 0.64391894 |
| 104 | MP0004130_abnormal_muscle_cell | 0.61737726 |
| 105 | MP0003045_fibrosis | 0.61360730 |
| 106 | MP0005409_darkened_coat_color | 0.60432561 |
| 107 | MP0002075_abnormal_coat/hair_pigmentati | 0.59911432 |
| 108 | MP0002877_abnormal_melanocyte_morpholog | 0.58812317 |
| 109 | MP0008874_decreased_physiological_sensi | 0.58482188 |
| 110 | MP0009765_abnormal_xenobiotic_induced | 0.57150674 |
| 111 | MP0005023_abnormal_wound_healing | 0.56110709 |
| 112 | MP0000249_abnormal_blood_vessel | 0.55440544 |
| 113 | MP0000598_abnormal_liver_morphology | 0.55060287 |
| 114 | MP0003795_abnormal_bone_structure | 0.54164959 |
| 115 | MP0003075_altered_response_to | 0.54114686 |
| 116 | MP0008873_increased_physiological_sensi | 0.53367558 |
| 117 | MP0000477_abnormal_intestine_morphology | 0.52859796 |
| 118 | MP0009115_abnormal_fat_cell | 0.50086646 |
| 119 | MP0004147_increased_porphyrin_level | 0.48402118 |
| 120 | MP0000920_abnormal_myelination | 0.48353061 |
| 121 | MP0005388_respiratory_system_phenotype | 0.48257832 |
| 122 | MP0002133_abnormal_respiratory_system | 0.48257832 |
| 123 | MP0005319_abnormal_enzyme/_coenzyme | 0.46192019 |
| 124 | MP0005381_digestive/alimentary_phenotyp | 0.44972887 |
| 125 | MP0003329_amyloid_beta_deposits | 0.44164134 |
| 126 | MP0003279_aneurysm | 0.42730652 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.34763967 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 5.00995180 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.77105891 |
| 4 | Thrombocytosis (HP:0001894) | 4.74563663 |
| 5 | IgM deficiency (HP:0002850) | 4.70361521 |
| 6 | Recurrent fungal infections (HP:0002841) | 4.30579063 |
| 7 | Recurrent viral infections (HP:0004429) | 4.11858645 |
| 8 | Chronic otitis media (HP:0000389) | 4.08731473 |
| 9 | Myositis (HP:0100614) | 3.90071584 |
| 10 | Cellulitis (HP:0100658) | 3.75851583 |
| 11 | Prolonged bleeding time (HP:0003010) | 3.75192398 |
| 12 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.71871164 |
| 13 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.71014231 |
| 14 | Recurrent skin infections (HP:0001581) | 3.62742924 |
| 15 | Gastrointestinal infarctions (HP:0005244) | 3.61859894 |
| 16 | Meningitis (HP:0001287) | 3.48537280 |
| 17 | Panhypogammaglobulinemia (HP:0003139) | 3.48203479 |
| 18 | Petechiae (HP:0000967) | 3.45432409 |
| 19 | Recurrent bronchitis (HP:0002837) | 3.39172926 |
| 20 | Abnormality of the fingertips (HP:0001211) | 3.34700540 |
| 21 | Mediastinal lymphadenopathy (HP:0100721) | 3.33823729 |
| 22 | Nasal polyposis (HP:0100582) | 3.31431239 |
| 23 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.30600583 |
| 24 | Recurrent cutaneous fungal infections (HP:0011370) | 3.26509215 |
| 25 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.26509215 |
| 26 | Obstructive lung disease (HP:0006536) | 3.23988435 |
| 27 | Chronic obstructive pulmonary disease (HP:0006510) | 3.23988435 |
| 28 | Gastrointestinal inflammation (HP:0004386) | 3.19320600 |
| 29 | Impaired platelet aggregation (HP:0003540) | 3.12800532 |
| 30 | Abnormal platelet function (HP:0011869) | 3.12800532 |
| 31 | Inflammation of the large intestine (HP:0002037) | 3.12629794 |
| 32 | Epistaxis (HP:0000421) | 3.10265357 |
| 33 | Keratoconjunctivitis sicca (HP:0001097) | 3.09009117 |
| 34 | Abnormality of macrophages (HP:0004311) | 3.08530417 |
| 35 | Abnormality of the nasal mucosa (HP:0000433) | 3.06499987 |
| 36 | Agammaglobulinemia (HP:0004432) | 3.06392057 |
| 37 | Periodontitis (HP:0000704) | 2.91180597 |
| 38 | Abnormality of T cell physiology (HP:0011840) | 2.85044396 |
| 39 | Abnormality of B cell number (HP:0010975) | 2.84615016 |
| 40 | B lymphocytopenia (HP:0010976) | 2.84615016 |
| 41 | Keratoconjunctivitis (HP:0001096) | 2.83199655 |
| 42 | Abnormality of T cells (HP:0002843) | 2.83025598 |
| 43 | Colitis (HP:0002583) | 2.82482478 |
| 44 | Vasculitis (HP:0002633) | 2.80865794 |
| 45 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.76732064 |
| 46 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.76732064 |
| 47 | Abnormality of glycolipid metabolism (HP:0010969) | 2.76732064 |
| 48 | Spontaneous hematomas (HP:0007420) | 2.75674770 |
| 49 | Gingival bleeding (HP:0000225) | 2.72117354 |
| 50 | Amyloidosis (HP:0011034) | 2.66766065 |
| 51 | Lymphopenia (HP:0001888) | 2.64206749 |
| 52 | Pustule (HP:0200039) | 2.64129425 |
| 53 | Systemic lupus erythematosus (HP:0002725) | 2.63421940 |
| 54 | T lymphocytopenia (HP:0005403) | 2.61671772 |
| 55 | Thyroiditis (HP:0100646) | 2.61119190 |
| 56 | Chest pain (HP:0100749) | 2.60983718 |
| 57 | Acute myeloid leukemia (HP:0004808) | 2.60407362 |
| 58 | Gastrointestinal stroma tumor (HP:0100723) | 2.58034488 |
| 59 | Episodic fever (HP:0001954) | 2.55929309 |
| 60 | Leukocytosis (HP:0001974) | 2.53920512 |
| 61 | Granulocytopenia (HP:0001913) | 2.53025495 |
| 62 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.52943067 |
| 63 | Orchitis (HP:0100796) | 2.52012215 |
| 64 | Osteomyelitis (HP:0002754) | 2.51871442 |
| 65 | Gingivitis (HP:0000230) | 2.50753888 |
| 66 | Pulmonary embolism (HP:0002204) | 2.50323318 |
| 67 | Autoimmune thrombocytopenia (HP:0001973) | 2.49859252 |
| 68 | Eosinophilia (HP:0001880) | 2.47916632 |
| 69 | Hypochromic microcytic anemia (HP:0004840) | 2.47702747 |
| 70 | Interstitial pulmonary disease (HP:0006530) | 2.45403990 |
| 71 | Abnormality of T cell number (HP:0011839) | 2.45039453 |
| 72 | Aplastic anemia (HP:0001915) | 2.43008281 |
| 73 | Vacuolated lymphocytes (HP:0001922) | 2.41379842 |
| 74 | Arterial thrombosis (HP:0004420) | 2.39896731 |
| 75 | Increased IgE level (HP:0003212) | 2.39375270 |
| 76 | Loss of speech (HP:0002371) | 2.37021663 |
| 77 | Purpura (HP:0000979) | 2.36884168 |
| 78 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.36517717 |
| 79 | Abnormality of the prostate (HP:0008775) | 2.35309438 |
| 80 | Dysostosis multiplex (HP:0000943) | 2.34223240 |
| 81 | Increased cerebral lipofuscin (HP:0011813) | 2.33694713 |
| 82 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.33179849 |
| 83 | Abnormal number of erythroid precursors (HP:0012131) | 2.32651270 |
| 84 | Abnormality of eosinophils (HP:0001879) | 2.31067641 |
| 85 | IgG deficiency (HP:0004315) | 2.30023593 |
| 86 | Anorexia (HP:0002039) | 2.28038116 |
| 87 | Stomatitis (HP:0010280) | 2.26874444 |
| 88 | Myelodysplasia (HP:0002863) | 2.26490392 |
| 89 | Amaurosis fugax (HP:0100576) | 2.25670971 |
| 90 | Optic neuritis (HP:0100653) | 2.25073459 |
| 91 | Retrobulbar optic neuritis (HP:0100654) | 2.25073459 |
| 92 | Increased IgM level (HP:0003496) | 2.24675550 |
| 93 | Reticulocytopenia (HP:0001896) | 2.22506880 |
| 94 | Thoracic kyphosis (HP:0002942) | 2.21465308 |
| 95 | Hemoptysis (HP:0002105) | 2.19206120 |
| 96 | Increased serum ferritin (HP:0003281) | 2.18160679 |
| 97 | Hepatosplenomegaly (HP:0001433) | 2.18103034 |
| 98 | Lymphoma (HP:0002665) | 2.16738627 |
| 99 | Albinism (HP:0001022) | 2.16537561 |
| 100 | Viral hepatitis (HP:0006562) | 2.16214136 |
| 101 | Sepsis (HP:0100806) | 2.15496287 |
| 102 | Hypergammaglobulinemia (HP:0010702) | 2.15302814 |
| 103 | Encephalitis (HP:0002383) | 2.15168611 |
| 104 | Hypoplasia of the thymus (HP:0000778) | 2.12443607 |
| 105 | IgA deficiency (HP:0002720) | 2.11745018 |
| 106 | Acute lymphatic leukemia (HP:0006721) | 2.11451979 |
| 107 | Abnormality of iron homeostasis (HP:0011031) | 2.10367119 |
| 108 | Papilloma (HP:0012740) | 2.08555895 |
| 109 | Verrucae (HP:0200043) | 2.08555895 |
| 110 | Abnormal platelet volume (HP:0011876) | 2.08441077 |
| 111 | Cheilitis (HP:0100825) | 2.08198700 |
| 112 | Abnormality of the pleura (HP:0002103) | 2.08136209 |
| 113 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.06722648 |
| 114 | Recurrent sinusitis (HP:0011108) | 2.06648969 |
| 115 | Abnormality of the thoracic spine (HP:0100711) | 2.03744070 |
| 116 | Chronic diarrhea (HP:0002028) | 2.03341872 |
| 117 | Peritonitis (HP:0002586) | 2.02657481 |
| 118 | Pulmonary infiltrates (HP:0002113) | 2.02012619 |
| 119 | Microcytic anemia (HP:0001935) | 2.00665028 |
| 120 | Hypochromic anemia (HP:0001931) | 2.00403380 |
| 121 | Agnosia (HP:0010524) | 1.98478382 |
| 122 | Chronic sinusitis (HP:0011109) | 1.97781808 |
| 123 | Skin ulcer (HP:0200042) | 1.97209003 |
| 124 | Fatigue (HP:0012378) | 1.96623145 |
| 125 | Hematochezia (HP:0002573) | 1.96489187 |
| 126 | Gangrene (HP:0100758) | 1.96412475 |
| 127 | Urticaria (HP:0001025) | 1.95369140 |
| 128 | Slow saccadic eye movements (HP:0000514) | 1.94291061 |
| 129 | Premature loss of primary teeth (HP:0006323) | 1.93245590 |
| 130 | Abnormality of the endocardium (HP:0004306) | 1.93214727 |
| 131 | Glomerulopathy (HP:0100820) | 1.91765692 |
| 132 | Abnormality of the peritoneum (HP:0002585) | 1.91287794 |
| 133 | Polygenic inheritance (HP:0010982) | 1.91271762 |
| 134 | Vertigo (HP:0002321) | 1.90875156 |
| 135 | Restrictive lung disease (HP:0002091) | 1.88020664 |
| 136 | Disinhibition (HP:0000734) | 1.85727566 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.81272080 |
| 2 | KIT | 2.82809170 |
| 3 | PRPF4B | 2.82611051 |
| 4 | EEF2K | 2.80330450 |
| 5 | IRAK4 | 2.68508908 |
| 6 | BTK | 2.53944507 |
| 7 | TXK | 2.44548129 |
| 8 | JAK3 | 2.32177539 |
| 9 | ZAP70 | 2.22329796 |
| 10 | CSF1R | 2.02574276 |
| 11 | BLK | 2.01731612 |
| 12 | TYK2 | 2.01294991 |
| 13 | TEC | 2.00867647 |
| 14 | SYK | 1.88997064 |
| 15 | TAOK3 | 1.88373535 |
| 16 | TGFBR2 | 1.85709856 |
| 17 | STK10 | 1.84008311 |
| 18 | SIK2 | 1.76553774 |
| 19 | RIPK4 | 1.75814984 |
| 20 | FES | 1.71043471 |
| 21 | MAP2K3 | 1.69214055 |
| 22 | TBK1 | 1.63092315 |
| 23 | FGR | 1.62687195 |
| 24 | MAP3K3 | 1.62320740 |
| 25 | HCK | 1.61015696 |
| 26 | FLT3 | 1.57215912 |
| 27 | GRK6 | 1.56511963 |
| 28 | IRAK3 | 1.52989982 |
| 29 | IKBKE | 1.49176032 |
| 30 | PKN2 | 1.46430986 |
| 31 | TAOK1 | 1.46237078 |
| 32 | MAP3K14 | 1.45076542 |
| 33 | MAP3K10 | 1.42811026 |
| 34 | MAP3K11 | 1.42663482 |
| 35 | ITK | 1.36343371 |
| 36 | LCK | 1.35019611 |
| 37 | ERN1 | 1.30674175 |
| 38 | NME2 | 1.27229268 |
| 39 | FGFR3 | 1.25897504 |
| 40 | MATK | 1.22639761 |
| 41 | IKBKB | 1.21655535 |
| 42 | LRRK2 | 1.18338301 |
| 43 | LYN | 1.18194214 |
| 44 | MAP3K1 | 1.15600290 |
| 45 | PIM1 | 1.13622174 |
| 46 | MARK2 | 1.13060594 |
| 47 | RPS6KA4 | 1.06298925 |
| 48 | TGFBR1 | 1.06214755 |
| 49 | MAP3K13 | 1.04405329 |
| 50 | JAK1 | 1.04192651 |
| 51 | TRPM7 | 1.02895358 |
| 52 | NEK2 | 1.02191725 |
| 53 | CLK1 | 1.00777439 |
| 54 | CSK | 1.00393027 |
| 55 | SIK3 | 0.99952491 |
| 56 | YES1 | 0.98500079 |
| 57 | RPS6KB2 | 0.98388980 |
| 58 | EPHB1 | 0.97002305 |
| 59 | BMPR2 | 0.96382335 |
| 60 | KSR2 | 0.93652266 |
| 61 | STK4 | 0.90223758 |
| 62 | CDC42BPA | 0.88435671 |
| 63 | PRKD2 | 0.87931489 |
| 64 | MAPK7 | 0.86840891 |
| 65 | CDC7 | 0.86789551 |
| 66 | MAPK12 | 0.86317025 |
| 67 | MARK3 | 0.82576658 |
| 68 | TNK2 | 0.79354169 |
| 69 | PDPK1 | 0.78362865 |
| 70 | CDK12 | 0.78301050 |
| 71 | SMG1 | 0.78210525 |
| 72 | CDK4 | 0.77647119 |
| 73 | TRIB3 | 0.77510921 |
| 74 | PIM2 | 0.77378798 |
| 75 | JAK2 | 0.74193133 |
| 76 | TAOK2 | 0.73393593 |
| 77 | CDK6 | 0.71781259 |
| 78 | IRAK1 | 0.71561597 |
| 79 | MAP3K6 | 0.71410635 |
| 80 | MAPKAPK5 | 0.71169525 |
| 81 | IRAK2 | 0.70919435 |
| 82 | ATR | 0.70563437 |
| 83 | HIPK2 | 0.70367736 |
| 84 | CAMK1D | 0.68138475 |
| 85 | PIK3CG | 0.67789203 |
| 86 | VRK1 | 0.66471118 |
| 87 | CHUK | 0.66463580 |
| 88 | PAK4 | 0.65808547 |
| 89 | PTK6 | 0.63755806 |
| 90 | FYN | 0.63137509 |
| 91 | MAPK4 | 0.61812603 |
| 92 | WEE1 | 0.61119942 |
| 93 | RPS6KA6 | 0.60728777 |
| 94 | FGFR4 | 0.59141346 |
| 95 | GRK7 | 0.57467631 |
| 96 | CAMK1G | 0.57273811 |
| 97 | TESK2 | 0.56699665 |
| 98 | PDK1 | 0.55545638 |
| 99 | CDK19 | 0.55348912 |
| 100 | NEK9 | 0.54477764 |
| 101 | CAMKK1 | 0.53896602 |
| 102 | MAPKAPK3 | 0.53373575 |
| 103 | SGK3 | 0.53285360 |
| 104 | RPS6KL1 | 0.50940462 |
| 105 | RPS6KC1 | 0.50940462 |
| 106 | DYRK1B | 0.50364526 |
| 107 | NLK | 0.48528815 |
| 108 | STK24 | 0.46301357 |
| 109 | MAPKAPK2 | 0.46189329 |
| 110 | STK11 | 0.46186134 |
| 111 | SIK1 | 0.46094843 |
| 112 | RPS6KA2 | 0.44299439 |
| 113 | RET | 0.43675178 |
| 114 | MAPK11 | 0.43078530 |
| 115 | MAP3K8 | 0.43061466 |
| 116 | DYRK3 | 0.43047076 |
| 117 | PASK | 0.40692964 |
| 118 | TIE1 | 0.40155507 |
| 119 | MOS | 0.39516926 |
| 120 | PTK2B | 0.39344326 |
| 121 | MAP3K5 | 0.39332877 |
| 122 | CDK9 | 0.38995692 |
| 123 | ALK | 0.38608025 |
| 124 | BRSK2 | 0.38380385 |
| 125 | MAP3K12 | 0.37159385 |
| 126 | MKNK1 | 0.36032497 |
| 127 | PRKCQ | 0.35752743 |
| 128 | CDK7 | 0.35541336 |
| 129 | MAP3K7 | 0.34747509 |
| 130 | SGK2 | 0.34740758 |
| 131 | TTN | 0.34063308 |
| 132 | ABL1 | 0.33336550 |
| 133 | MAP2K6 | 0.33002864 |
| 134 | CAMKK2 | 0.32808873 |
| 135 | MAPK3 | 0.32224541 |
| 136 | MAP2K2 | 0.31571783 |
| 137 | MAP3K2 | 0.31486502 |
| 138 | MAP2K4 | 0.31461322 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.16076617 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.80596784 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.74187081 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.35754005 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.29932104 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.28496290 |
| 7 | DNA replication_Homo sapiens_hsa03030 | 2.21932885 |
| 8 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.08479414 |
| 9 | Measles_Homo sapiens_hsa05162 | 2.04415829 |
| 10 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.03589619 |
| 11 | Other glycan degradation_Homo sapiens_hsa00511 | 1.96541197 |
| 12 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.93355064 |
| 13 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.92164534 |
| 14 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.89345064 |
| 15 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.87182688 |
| 16 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.81291063 |
| 17 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.81220445 |
| 18 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.80805500 |
| 19 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.76321290 |
| 20 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.74640016 |
| 21 | Ribosome_Homo sapiens_hsa03010 | 1.73195275 |
| 22 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.72628650 |
| 23 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.67773735 |
| 24 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.60428436 |
| 25 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.56830329 |
| 26 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.56481470 |
| 27 | Mismatch repair_Homo sapiens_hsa03430 | 1.56382371 |
| 28 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.51390638 |
| 29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.45337641 |
| 30 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.44672085 |
| 31 | Tuberculosis_Homo sapiens_hsa05152 | 1.42349326 |
| 32 | Base excision repair_Homo sapiens_hsa03410 | 1.40985153 |
| 33 | Pertussis_Homo sapiens_hsa05133 | 1.40934718 |
| 34 | Influenza A_Homo sapiens_hsa05164 | 1.40237815 |
| 35 | Shigellosis_Homo sapiens_hsa05131 | 1.37229904 |
| 36 | Legionellosis_Homo sapiens_hsa05134 | 1.36855153 |
| 37 | Hepatitis B_Homo sapiens_hsa05161 | 1.36691758 |
| 38 | * Platelet activation_Homo sapiens_hsa04611 | 1.36567678 |
| 39 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.31987783 |
| 40 | Homologous recombination_Homo sapiens_hsa03440 | 1.31593321 |
| 41 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.31178419 |
| 42 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.29712921 |
| 43 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.26434744 |
| 44 | Apoptosis_Homo sapiens_hsa04210 | 1.25808825 |
| 45 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.21213004 |
| 46 | * Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.21039655 |
| 47 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.16043945 |
| 48 | Asthma_Homo sapiens_hsa05310 | 1.13843741 |
| 49 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.13063846 |
| 50 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.10358013 |
| 51 | Malaria_Homo sapiens_hsa05144 | 1.10065785 |
| 52 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.03389805 |
| 53 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.97722317 |
| 54 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.96101890 |
| 55 | Spliceosome_Homo sapiens_hsa03040 | 0.95496925 |
| 56 | Salmonella infection_Homo sapiens_hsa05132 | 0.92996910 |
| 57 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.91830640 |
| 58 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.90389365 |
| 59 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.90188511 |
| 60 | Allograft rejection_Homo sapiens_hsa05330 | 0.89840467 |
| 61 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.88408123 |
| 62 | Lysosome_Homo sapiens_hsa04142 | 0.85225516 |
| 63 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.84357775 |
| 64 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.81099305 |
| 65 | Hepatitis C_Homo sapiens_hsa05160 | 0.79125080 |
| 66 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.78578240 |
| 67 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.78576212 |
| 68 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.77837182 |
| 69 | HTLV-I infection_Homo sapiens_hsa05166 | 0.77123691 |
| 70 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.76998560 |
| 71 | Cell cycle_Homo sapiens_hsa04110 | 0.75891664 |
| 72 | Viral myocarditis_Homo sapiens_hsa05416 | 0.72519189 |
| 73 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.71936022 |
| 74 | * AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.71477680 |
| 75 | Endocytosis_Homo sapiens_hsa04144 | 0.70326188 |
| 76 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.70094651 |
| 77 | * Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.69426712 |
| 78 | * African trypanosomiasis_Homo sapiens_hsa05143 | 0.68557693 |
| 79 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.68449149 |
| 80 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.67831082 |
| 81 | Sulfur relay system_Homo sapiens_hsa04122 | 0.67449907 |
| 82 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.67050017 |
| 83 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.66518314 |
| 84 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.65612717 |
| 85 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.64273617 |
| 86 | * Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.63412568 |
| 87 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.63332513 |
| 88 | RNA degradation_Homo sapiens_hsa03018 | 0.62160984 |
| 89 | * Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.61647361 |
| 90 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.58290191 |
| 91 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.58250754 |
| 92 | Endometrial cancer_Homo sapiens_hsa05213 | 0.57869089 |
| 93 | * GnRH signaling pathway_Homo sapiens_hsa04912 | 0.56999444 |
| 94 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.56063773 |
| 95 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.55700929 |
| 96 | Colorectal cancer_Homo sapiens_hsa05210 | 0.54561807 |
| 97 | ABC transporters_Homo sapiens_hsa02010 | 0.53589655 |
| 98 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.53088744 |
| 99 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.51906098 |
| 100 | * Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.51876196 |
| 101 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.51686369 |
| 102 | * Amoebiasis_Homo sapiens_hsa05146 | 0.51126836 |
| 103 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.50524677 |
| 104 | Lysine degradation_Homo sapiens_hsa00310 | 0.50184672 |
| 105 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.49425835 |
| 106 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.48975011 |
| 107 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.47843066 |
| 108 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.47764743 |
| 109 | * Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.45590653 |
| 110 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.45291257 |
| 111 | Phagosome_Homo sapiens_hsa04145 | 0.44678602 |
| 112 | Insulin resistance_Homo sapiens_hsa04931 | 0.42039626 |
| 113 | * Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.41332598 |
| 114 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.40264762 |
| 115 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.39507015 |
| 116 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.38674503 |
| 117 | * Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.38185113 |
| 118 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.37941824 |
| 119 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.36138725 |
| 120 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.35896459 |
| 121 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.35144685 |
| 122 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.34837911 |
| 123 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.33853815 |
| 124 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.33732624 |
| 125 | Prostate cancer_Homo sapiens_hsa05215 | 0.33396976 |
| 126 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.32957699 |
| 127 | RNA transport_Homo sapiens_hsa03013 | 0.32094205 |
| 128 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.31792677 |
| 129 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.29818960 |

